Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Detalles Bibliográficos
Autor principal: International, BioMed Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307199/
https://www.ncbi.nlm.nih.gov/pubmed/37388379
http://dx.doi.org/10.1155/2023/9870382
_version_ 1785065990942359552
author International, BioMed Research
author_facet International, BioMed Research
author_sort International, BioMed Research
collection PubMed
description
format Online
Article
Text
id pubmed-10307199
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103071992023-06-29 Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer International, BioMed Research Biomed Res Int Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307199/ /pubmed/37388379 http://dx.doi.org/10.1155/2023/9870382 Text en Copyright © 2023 BioMed Research International. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
International, BioMed Research
Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
title Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
title_full Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
title_fullStr Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
title_full_unstemmed Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
title_short Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
title_sort retracted: cell division cycle-associated protein 3 (cdca3) is a potential biomarker for clinical prognosis and immunotherapy in pan-cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307199/
https://www.ncbi.nlm.nih.gov/pubmed/37388379
http://dx.doi.org/10.1155/2023/9870382
work_keys_str_mv AT internationalbiomedresearch retractedcelldivisioncycleassociatedprotein3cdca3isapotentialbiomarkerforclinicalprognosisandimmunotherapyinpancancer

Ejemplares similares